SUMMIT, N.J.--(BUSINESS WIRE)--May. 31, 2013--
Celgene Corporation (NASDAQ: CELG), announced today the initiation of
the “Innovation Impact” Awards to recognize effective, innovative and
successful initiatives in one of two therapeutic areas: hematology or
oncology. The program aims to recognize the achievements of US-based
not-for-profit organizations addressing the needs of patients,
caregivers and healthcare providers in today’s challenging healthcare
“The Innovation Impact Awards represent an opportunity to highlight
initiatives that have had a demonstrable impact on the lives of
patients, families, caregivers and/or the medical professionals who
provide treatment and care,” said Joel Beetsch, Vice President, Patient
Advocacy at Celgene. “One of Celgene’s goals with the Innovation Impact
Awards is to ensure that the selected programs have an opportunity to
flourish and evolve. That’s why we’re asking participants to share plans
on how they plan to build on their success and take their program to the
Applications are now being accepted. Submissions must demonstrate
inspired innovation, a validated need, proven impact, measurable results
and show how it will build on its current success. An independent
judging panel comprised of innovation, healthcare and advocacy experts
will select two winners; one in oncology and one in hematology.
Winners will be announced by October 15, 2013 and each winner will
receive a $100,000 monetary award. Award winners will be invited to
participate in an exclusive day-long “Innovation Experience” that will
feature a workshop led by an innovation expert.
Applications are restricted to patient and professional organizations
and associations with an interest in hematology or oncology.
Organizations must be classified as a not-for-profit and headquartered
in the United States. Consideration for awards will not be given to
individuals, medical facilities or research institutions. Nor will
applications be accepted for pre-clinical, clinical or translational
research programs. Each organization may submit only one entry.
For more information visit http://www.innovationimpact.com
to learn more about our Awards program, including: the evaluation
criteria, experts serving on our judging panel, frequently asked
questions, and terms and conditions for the Awards.
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global pharmaceutical company engaged primarily in the
discovery, development and commercialization of innovative therapies for
the treatment of cancer and inflammatory diseases through gene and
For more information, please visit the Company's website at www.celgene.com.
Source: Celgene Corporation